MAM
FATE icon

Monaco Asset Management’s Fate Therapeutics FATE Stock Holding History

Monaco Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-810,000
Closed -$972K – 56
2026
Q1 		$972K Sell
810,000
-20,000
-2% -$24.4K 0.18% 51
2025
Q4 		$816K Buy
830,000
+60,000
+8% +$72K 0.14% 68
2025
Q3 		$970K Buy
770,000
+95,000
+14% +$102K 0.06% 67
2025
Q2 		$756K Sell
675,000
-474,708
-41% -$552K 0.13% 75
2025
Q1 		$908K Buy
1,149,708
+822,037
+251% +$1.01M 0.19% 53
2024
Q4 		$541K Buy
327,671
+190,000
+138% +$479K 0.08% 71
2024
Q3 		$482K Sell
137,671
-149,229
-52% -$581K 0.07% 65
2024
Q2 		$941K Sell
286,900
-29,905
-9% -$131K 0.15% 47
2024
Q1 		$2.33M Sell
316,805
-1,866,423
-85% -$11.6M 0.7% 28
2023
Q4 		$8.17M Buy
2,183,228
+335,284
+18% +$791K 2.4% 12
2023
Q3 		$3.92M Buy
1,847,944
+842,718
+84% +$2.79M 1.16% 22
2023
Q2 		$4.78M Buy
1,005,226
+34,933
+4% +$193K 1.34% 21
2023
Q1 		$5.53M Buy
970,293
+720,293
+288% +$4.35M 1.7% 17
2022
Q4 		$2.52M Buy
+250,000
New +$4.7M 0.76% 37

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Monaco Asset Management's FATE Position: Q2 2026 in Review

Monaco Asset Management sold out of Fate Therapeutics (FATE) in Q2 2026, closing a stake of 810,000 shares — an estimated $972K sold.

Monaco Asset Management first reported a position in FATE in Q4 2022 and held it in 14 quarters. The position peaked at $8.17M in Q4 2023. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Monaco Asset Management reported no remaining Fate Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Monaco Asset Management sold 810,000 Fate Therapeutics shares in Q2 2026, an estimated $972K.
  • Monaco Asset Management first reported a position in Fate Therapeutics in Q4 2022 and held it in 14 quarters.
  • Monaco Asset Management's Fate Therapeutics position peaked at $8.17M in Q4 2023.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.